Vytorin, Zetia squeeze manufacturers
The cholesterol-fighting drugs Zetia and Vytorin, blockbuster drugs that once represented multi-billion dollar sales for Schering-Plough and Merck, now seem to be squeezing the pharmaceutical giants.
Attorney Consultation
Verdict
› $4.85 Billion settlement in drug case